Glaukos Total Liabilities and Share Holders Equity 2014-2025 | GKOS
Glaukos total liabilities and share holders equity from 2014 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Glaukos total liabilities and share holders equity for the quarter ending March 31, 2025 was $0.966B, a 3.52% increase year-over-year.
- Glaukos total liabilities and share holders equity for 2024 was $0.975B, a 3.65% increase from 2023.
- Glaukos total liabilities and share holders equity for 2023 was $0.94B, a 6.18% decline from 2022.
- Glaukos total liabilities and share holders equity for 2022 was $1.002B, a 4.51% decline from 2021.
| Glaukos Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024 | $975 |
| 2023 | $940 |
| 2022 | $1,002 |
| 2021 | $1,050 |
| 2020 | $1,006 |
| 2019 | $818 |
| 2018 | $207 |
| 2017 | $166 |
| 2016 | $134 |
| 2015 | $117 |
| 2014 | $26 |
| 2013 | $31 |
| Glaukos Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $966 |
| 2024-12-31 | $975 |
| 2024-09-30 | $927 |
| 2024-06-30 | $920 |
| 2024-03-31 | $933 |
| 2023-12-31 | $940 |
| 2023-09-30 | $949 |
| 2023-06-30 | $957 |
| 2023-03-31 | $973 |
| 2022-12-31 | $1,002 |
| 2022-09-30 | $1,008 |
| 2022-06-30 | $1,031 |
| 2022-03-31 | $1,052 |
| 2021-12-31 | $1,050 |
| 2021-09-30 | $1,064 |
| 2021-06-30 | $1,044 |
| 2021-03-31 | $1,023 |
| 2020-12-31 | $1,006 |
| 2020-09-30 | $995 |
| 2020-06-30 | $996 |
| 2020-03-31 | $780 |
| 2019-12-31 | $818 |
| 2019-09-30 | $307 |
| 2019-06-30 | $302 |
| 2019-03-31 | $228 |
| 2018-12-31 | $207 |
| 2018-09-30 | $191 |
| 2018-06-30 | $171 |
| 2018-03-31 | $163 |
| 2017-12-31 | $166 |
| 2017-09-30 | $153 |
| 2017-06-30 | $146 |
| 2017-03-31 | $138 |
| 2016-12-31 | $134 |
| 2016-09-30 | $129 |
| 2016-06-30 | $124 |
| 2016-03-31 | $116 |
| 2015-12-31 | $117 |
| 2015-09-30 | $118 |
| 2015-06-30 | $128 |
| 2015-03-31 | $28 |
| 2014-12-31 | $26 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.485B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $179.908B | 74.58 |
| Thermo Fisher Scientific (TMO) | United States | $176.180B | 21.32 |
| Alcon (ALC) | Switzerland | $45.487B | 30.74 |
| Edwards Lifesciences (EW) | United States | $45.115B | 29.58 |
| IDEXX Laboratories (IDXX) | United States | $43.483B | 49.97 |
| DexCom (DXCM) | United States | $33.890B | 52.38 |
| IQVIA Holdings (IQV) | United States | $33.021B | 18.66 |
| Mettler-Toledo (MTD) | United States | $26.128B | 31.07 |
| STERIS (STE) | Ireland | $22.180B | 24.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.745B | 0.00 |
| Waters (WAT) | United States | $17.593B | 24.82 |
| Hologic (HOLX) | United States | $14.697B | 15.97 |
| Sysmex ADR (SSMXY) | Japan | $10.821B | 30.70 |
| Penumbra (PEN) | United States | $9.038B | 70.94 |
| Masimo (MASI) | United States | $8.946B | 33.00 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Teleflex (TFX) | United States | $5.181B | 8.55 |
| Integer Holdings (ITGR) | United States | $4.039B | 21.17 |
| TransMedics (TMDX) | United States | $3.720B | 80.86 |
| PROCEPT BioRobotics (PRCT) | United States | $3.323B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.406B | 14.32 |
| Nihon Kohden (NHNKY) | Japan | $2.154B | 24.71 |
| Elekta AB (EKTAY) | Sweden | $1.952B | 17.55 |
| Veracyte (VCYT) | United States | $1.896B | 26.60 |
| Alphatec Holdings (ATEC) | United States | $1.583B | 0.00 |
| Artivion (AORT) | United States | $1.334B | 124.96 |
| OPKO Health (OPK) | United States | $1.134B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.076B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.995B | 5.29 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| IRadimed (IRMD) | United States | $0.725B | 36.77 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AxoGen (AXGN) | United States | $0.613B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| Semler Scientific (SMLR) | United States | $0.542B | 11.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.451B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.411B | 9.54 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.382B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.324B | 0.00 |
| RxSight (RXST) | United States | $0.321B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.244B | 14.76 |
| CVRx (CVRX) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.205B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.54 |